Skip to Content

Join the 'Provenge' group to help and get support from people like you.

Provenge News

Drones Could Deliver Vaccines in Developing Countries

Posted 25 Jun 2016 by Drugs.com

FRIDAY, June 24, 2016 – Right now, people often associate the use of drones with warfare. But in the future they could serve humanitarian purposes, such as delivering aid to people in developing countries. For example, the pilotless flying machines might offer a cheaper and better way to deliver vaccines. And that could potentially boost vaccination rates in areas that can be difficult to reach now, a new study suggests. Using a computer model, researchers concluded that sending drones to deliver vaccines in low- and middle-income countries would be cheaper and quicker than by land-based vehicles. Cars and trucks are limited by road conditions and have high fuel and maintenance costs, the researchers said. "Many low- and middle-income countries are struggling to get lifesaving vaccines to people to keep them from getting sick or dying from preventable diseases," said senior study ... Read more

Related support groups: BCG, Zostavax, Yellow Fever Vaccine, Gardasil, Prevnar 13, Prevnar, Tetanus Toxoid, Vivotif Berna, Rabies Vaccine, Human Diploid Cell, Hepatitis B Adult Vaccine, Typhoid Vaccine, Live, FluLaval, Varicella Virus Vaccine, Vivotif Berna Vaccine, Measles Virus Vaccine, Rotarix, Human Papillomavirus Vaccine, Smallpox Vaccine, Pneumovax 23, Cervarix

California Vaccine Refusers Cluster in Rich, White Areas

Posted 12 Nov 2015 by Drugs.com

THURSDAY, Nov. 12, 2015 – California's anti-vaccine sentiment tends to concentrate in wealthier, largely white areas of the state – a pattern that has left certain communities with childhood vaccination rates as low as 50 percent, a new study finds. The study, published online Nov. 12 in the American Journal of Public Health, is the latest to delve into the issue of personal belief exemptions for vaccines. Right now, 20 U.S. states permit the exemptions, which allow parents to opt out of routine childhood vaccinations based on philosophical objections. California is technically still one of those states, but a law passed earlier this year will end personal belief exemptions in that state in July 2016, according to the National Conference of State Legislatures (NCSL). The new law came largely in response to this year's measles outbreak, which sickened 189 people in 24 U.S. states and ... Read more

Related support groups: BCG, Zostavax, Yellow Fever Vaccine, Gardasil, Prevnar 13, Prevnar, Tetanus Toxoid, Vivotif Berna, Rabies Vaccine, Human Diploid Cell, Typhoid Vaccine, Live, FluLaval, Hepatitis B Adult Vaccine, Twinrix, Varicella Virus Vaccine, Vivotif Berna Vaccine, Afluria, Human Papillomavirus Vaccine, Pneumovax 23, Rotarix, Cervarix

Anti-Vaccine Parents Cluster in Rich, White Areas

Posted 3 Jun 2015 by Drugs.com

WEDNESDAY, June 3, 2015 – Parents who cite "personal beliefs" to get their children exempted from routine vaccinations are typically white and well-to-do – at least in California, a new study finds. The results, published June 1 in Pediatrics, confirm what other studies have suggested: Anti-vaccine sentiment in the United States appears strongest among wealthier white families. But the study also found another pattern that surprised experts: California schools with high rates of personal-belief exemptions often had high rates of exemptions for medical reasons, too. "There's no clear explanation for why that would be," said Dr. Paul Offit, chief of infectious diseases at Children's Hospital of Philadelphia, who was not involved in the study. But the concern, he added, is that some children exempted for medical reasons could be put at risk if their classmates are not vaccinated against ... Read more

Related support groups: BCG, Zostavax, Yellow Fever Vaccine, Gardasil, Prevnar 13, Prevnar, Measles, Tetanus Toxoid, Vivotif Berna, Rabies Vaccine, Human Diploid Cell, FluLaval, Typhoid Vaccine, Live, Hepatitis B Adult Vaccine, Varicella Virus Vaccine, Twinrix, Vivotif Berna Vaccine, Afluria, Smallpox Vaccine, Pneumococcal 23-polyvalent Vaccine, Provenge

New Guidelines for Treating Advanced Prostate Cancer

Posted 8 Sep 2014 by Drugs.com

MONDAY, Sept. 8, 2014 – Men newly diagnosed with prostate cancer often turn first to testosterone-depleting therapies, since male hormones help prostate tumors grow. But, those therapies almost always fail over time as the tumor develops resistance, according to oncologists. Now, experts are issuing updated guidelines to help patients in this situation decide what to do next. The guidelines, issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) in Canada, highlight recent advances in treating this more advanced form of prostate cancer. "We have seen unprecedented progress against advanced prostate cancer recently, with six new treatments approved in the last couple of years," Dr. Ethan Basch, co-chair of the ASCO/CCO panel of experts that developed the guidelines, said in a news release from the two groups. "There are a lot of nuances about ... Read more

Related support groups: Prostate Cancer, Ketoconazole, Zytiga, Nizoral, Casodex, Taxotere, Xtandi, Bicalutamide, Provenge, Docetaxel, Abiraterone, Xofigo, Flutamide, Sipuleucel-t, Radium 223 Dichloride, Cabazitaxel, Jevtana, Novantrone, Enzalutamide, Eulexin

Vaccines Might Become Another Way to Fight Cancer

Posted 18 Jan 2013 by Drugs.com

FRIDAY, Jan. 18 – Most people think of the flu when the word "vaccine" comes up in conversation, but several vaccines also exist to help prevent cancers. Not only that, numerous researchers are also working to harness the power of the body's immune system to develop vaccines to help treat cancer. "Essentially, cancer treatment vaccines are the ultimate in personalized medicine," said Dr. Linda Liau, director of the brain tumor program at the University of California, Los Angeles. Liau is currently researching a brain cancer treatment vaccine. Dr. Jeffrey Hardacre, who's researching a pancreatic cancer vaccine, agreed. "This is an area that remains in its infancy, and I think we only have brighter things to look forward to," he said. "Using the body's immune system is a potent way to fight cancers." Hardacre is an associate professor of surgery and head of the pancreatic surgery section ... Read more

Related support groups: Hepatitis B, Pancreatic Cancer, Condylomata Acuminata, Gardasil, Hepatitis B Adult Vaccine, Twinrix, Human Papillomavirus Vaccine, Cervarix, Provenge, Sipuleucel-t, Engerix-B, Hepatitis A Adult Vaccine/hepatitis B Adult Vaccine

Vaccinations Aren't Just for Kids

Posted 16 Sep 2011 by Drugs.com

FRIDAY, Sept. 16 – Public health experts often focus immunization awareness efforts toward protecting children, and with good reason: Facing a potentially bewildering schedule of vaccinations for their young ones, parents usually need all the help they can get. But vaccinations aren't just kid stuff. Medical science is creating an increasing number of immunizations targeted at adults, to help them avoid life-threatening diseases in middle-age and opportunistic infections when they're older. "Immunization is a life-long issue that we need to pay a lot of attention to," said Dr. Georges C. Benjamin, executive director of the American Public Health Association. Some adult vaccinations are very well-known, like the annual shot that aims to prevent the spread of influenza. "You need an influenza shot every year," Benjamin said. "Part of that is because the virus changes every year, ... Read more

Related support groups: Pneumonia, Human Papilloma Virus, BCG, Meningitis, Tetanus, Zostavax, Yellow Fever Vaccine, Condylomata Acuminata, Gardasil, Cervical Cancer, Prevnar 13, Prevnar, Varicella-Zoster, Measles, Tetanus Toxoid, Tuberculosis - Prophylaxis, Vivotif Berna, Rubella, Rabies Vaccine, Human Diploid Cell, FluLaval

Medicare Will Pay for Pricey Prostate Cancer Drug

Posted 30 Jun 2011 by Drugs.com

THURSDAY, June 30 – The cost of Provenge, an expensive and newly approved therapeutic prostate cancer vaccine, will be covered by Medicare for men with metastatic prostate cancer, the agency announced late Thursday. The vaccine, made by the Dendreon Corp., costs $93,000 per patient and extends survival by about four months on average, according to results from clinical trials. A panel of experts convened by Medicare gave the nod for coverage last November, but the agency has only now announced it would cover the treatment. "We are optimistic that innovative strategies may improve the experience of care for our beneficiaries who have cancer," Dr. Donald M. Berwick, administrator of the Centers for Medicare & Medicaid Services (CMS), said in an agency news release. "CMS is dedicated to assuring that these patients can seek the treatments they need in accordance with their wishes." ... Read more

Related support groups: Prostate Cancer, Provenge

Medicare Panel Endorses Vaccine for Prostate Cancer Patients

Posted 18 Nov 2010 by Drugs.com

WEDNESDAY, Nov. 17 – A newly approved therapeutic prostate cancer vaccine won the support Wednesday of a Medicare advisory committee, increasing the chances that Medicare will pay for the drug. Officials from Medicare, the federal insurance program for the elderly and disabled, will consider the committee's vote when making a final decision on payment. Such a decision is expected in several months, the Wall Street Journal reported. The vaccine, called Provenge and made by the Dendreon Corp., costs $93,000 per patient and extends survival by about four months on average, according to results from clinical trials. A study published in July in the New England Journal of Medicine found that the vaccine extended the lives of men with metastatic tumors resistant to standard hormonal treatment, compared with no treatment. And the therapy involved less toxicity than chemotherapy. Provenge is a ... Read more

Related support groups: Prostate Cancer, Provenge

How Much Is A Life Worth? $93,000 Cancer Drug Pushes Boundaries, And Patients Feel The Pinch

Posted 27 Sep 2010 by Drugs.com

BOSTON, September 26, 2010 – Cancer patients, brace yourselves. Many new drug treatments cost nearly $100,000 a year, sparking fresh debate about how much a few months more of life is worth. The latest is Provenge, a first-of-a-kind therapy approved in April. It costs $93,000 a year and adds four months’ survival, on average, for men with incurable prostate tumors. Bob Svensson is honest about why he got it: insurance paid. ``I would not spend that money,’’ because the benefit doesn’t seem worth it, says Svensson, 80, a former corporate finance officer from Bedford, Massachusetts. His supplemental Medicare plan is paying while the government decides whether basic Medicare will cover Provenge and for whom. The tab for taxpayers could be huge – prostate is the most common cancer in American men. Most of those who have it will be eligible for Medicare, and Provenge will be an option for m ... Read more

Related support groups: Provenge

Ask a Question

Further Information

Related Condition Support Groups

Prostate Cancer

Provenge Patient Information at Drugs.com